CNS Pharmaceuticals Inc (CNSP) — Financial Flexibility Index
CNS Pharmaceuticals Inc (CNSP) has a Financial Flexibility Index of -0.95x as of June 2026. Free cash flow of $-3.54 Million (operating CF $-3.54 Million minus capex $3.82K) represents -1% of total liabilities ($3.74 Million). Check CNSP intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CNS Pharmaceuticals Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for CNS Pharmaceuticals Inc across 9 annual periods. For the full cash flow conversion analysis, see CNS Pharmaceuticals Inc cash flow conversion.
Annual Financial Flexibility Index for CNS Pharmaceuticals Inc (2017–2025)
Year-by-year free cash flow to debt coverage for CNS Pharmaceuticals Inc. Explore how well can CNS Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.36x | $-13.79 Million | $-13.81 Million | $4.10 Million | ▲ +50.4% |
| 2024 | -6.78x | $-17.11 Million | $-17.11 Million | $2.52 Million | ▼ -194.0% |
| 2023 | -2.30x | $-14.14 Million | $-14.14 Million | $6.13 Million | ▼ -7.5% |
| 2022 | -2.14x | $-10.55 Million | $-10.56 Million | $4.92 Million | ▲ +66.2% |
| 2021 | -6.34x | $-13.53 Million | $-13.54 Million | $2.14 Million | ▼ -65.4% |
| 2020 | -3.83x | $-7.30 Million | $-7.32 Million | $1.91 Million | ▲ +66.3% |
| 2019 | -11.36x | $-3.53 Million | $-3.55 Million | $311.00K | ▼ -1854.9% |
| 2018 | -0.58x | $-716.38K | $-716.38K | $1.23 Million | ▼ -14.3% |
| 2017 | -0.51x | $-112.19K | $-112.20K | $220.73K | — |